Cargando…

Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants

It is believed that an individual’s hereditary factors may be involved in the development of esophageal cancer (EC). The present study recruited 721 esophageal squamous cell carcinoma (ESCC) cases and 1208 controls and explored the roles of single nucleotide polymorphisms (SNPs) in the interleukin-4...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuchen, Cao, Rui, Liu, Chao, Tang, Weifeng, Kang, Mingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419785/
https://www.ncbi.nlm.nih.gov/pubmed/32744314
http://dx.doi.org/10.1042/BSR20193895
_version_ 1783569949513482240
author Chen, Shuchen
Cao, Rui
Liu, Chao
Tang, Weifeng
Kang, Mingqiang
author_facet Chen, Shuchen
Cao, Rui
Liu, Chao
Tang, Weifeng
Kang, Mingqiang
author_sort Chen, Shuchen
collection PubMed
description It is believed that an individual’s hereditary factors may be involved in the development of esophageal cancer (EC). The present study recruited 721 esophageal squamous cell carcinoma (ESCC) cases and 1208 controls and explored the roles of single nucleotide polymorphisms (SNPs) in the interleukin-4 (IL-4), IL-10, and herpesvirus entry mediator (HVEM) genes in contributing to ESCC risk. IL-4, IL-10, and HVEM SNPs were analyzed by employing an SNPscan method. After adjustment for body mass index (BMI), smoking, drinking, age and gender, we identified that the rs2070874 T>C locus in IL-4 gene decreased the risk of ESCC (CC vs. TT: P=0.008; CC vs. TT/TC: P=0.010). After a stratified analysis, we suggested that the IL-4 rs2070874 T>C variants might be a protective factor for ESCC in male, ≥63 years old, never smoking, drinking and BMI < 24 kg/m(2) subgroups. In addition, we identified that the rs2243263 G>C polymorphism in IL-4 gene was a risk factor for ESCC development in the BMI ≥ 24 kg/m(2) subgroup (GC vs. GG: P=0.030 and GC/CC vs. GG: P=0.018). We identified an association of the IL-4 rs2070874 T>C SNP with the decreased susceptibility of ESCC in stage I/II subgroup. Finally, we found an association of the IL-10 rs1800872 T>G SNP with a worse differentiation (TG vs. TT: P=0.048 and GG/TG vs. TT: P=0.032). In conclusion, the findings indicate a potential importance of IL-4 rs2070874 T>C, IL-4 rs2243263 G>C and IL-10 rs1800872 T>G SNPs in the development of ESCC.
format Online
Article
Text
id pubmed-7419785
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74197852020-08-19 Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants Chen, Shuchen Cao, Rui Liu, Chao Tang, Weifeng Kang, Mingqiang Biosci Rep Cancer It is believed that an individual’s hereditary factors may be involved in the development of esophageal cancer (EC). The present study recruited 721 esophageal squamous cell carcinoma (ESCC) cases and 1208 controls and explored the roles of single nucleotide polymorphisms (SNPs) in the interleukin-4 (IL-4), IL-10, and herpesvirus entry mediator (HVEM) genes in contributing to ESCC risk. IL-4, IL-10, and HVEM SNPs were analyzed by employing an SNPscan method. After adjustment for body mass index (BMI), smoking, drinking, age and gender, we identified that the rs2070874 T>C locus in IL-4 gene decreased the risk of ESCC (CC vs. TT: P=0.008; CC vs. TT/TC: P=0.010). After a stratified analysis, we suggested that the IL-4 rs2070874 T>C variants might be a protective factor for ESCC in male, ≥63 years old, never smoking, drinking and BMI < 24 kg/m(2) subgroups. In addition, we identified that the rs2243263 G>C polymorphism in IL-4 gene was a risk factor for ESCC development in the BMI ≥ 24 kg/m(2) subgroup (GC vs. GG: P=0.030 and GC/CC vs. GG: P=0.018). We identified an association of the IL-4 rs2070874 T>C SNP with the decreased susceptibility of ESCC in stage I/II subgroup. Finally, we found an association of the IL-10 rs1800872 T>G SNP with a worse differentiation (TG vs. TT: P=0.048 and GG/TG vs. TT: P=0.032). In conclusion, the findings indicate a potential importance of IL-4 rs2070874 T>C, IL-4 rs2243263 G>C and IL-10 rs1800872 T>G SNPs in the development of ESCC. Portland Press Ltd. 2020-08-11 /pmc/articles/PMC7419785/ /pubmed/32744314 http://dx.doi.org/10.1042/BSR20193895 Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
spellingShingle Cancer
Chen, Shuchen
Cao, Rui
Liu, Chao
Tang, Weifeng
Kang, Mingqiang
Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
title Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
title_full Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
title_fullStr Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
title_full_unstemmed Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
title_short Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
title_sort investigation of il-4, il-10, and hvem polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
topic Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419785/
https://www.ncbi.nlm.nih.gov/pubmed/32744314
http://dx.doi.org/10.1042/BSR20193895
work_keys_str_mv AT chenshuchen investigationofil4il10andhvempolymorphismswithesophagealsquamouscellcarcinomaacasecontrolstudyinvolving1929participants
AT caorui investigationofil4il10andhvempolymorphismswithesophagealsquamouscellcarcinomaacasecontrolstudyinvolving1929participants
AT liuchao investigationofil4il10andhvempolymorphismswithesophagealsquamouscellcarcinomaacasecontrolstudyinvolving1929participants
AT tangweifeng investigationofil4il10andhvempolymorphismswithesophagealsquamouscellcarcinomaacasecontrolstudyinvolving1929participants
AT kangmingqiang investigationofil4il10andhvempolymorphismswithesophagealsquamouscellcarcinomaacasecontrolstudyinvolving1929participants